Showing results (11-20 of 278) with videos related to
Sort By:
Pageof 28
Current Pharmaceutical Design|February 7, 2003
Progress in developing D3 dopamine receptor ligands as potential therapeutic agents for neurological and neuropsychiatric disordersRobert R Luedtkea, Robert H MachJournal of Labelled Compounds & Radiopharmaceuticals|September 1, 2017
Challenges in the development of dopamine D2- and D3-selective radiotracers for PET imaging studiesRobert H Mach, Robert R LuedtkeOrganic Letters|October 14, 2016
Pd-Catalyzed Synthesis of Piperazine Scaffolds Under Aerobic and Solvent-Free ConditionsSean W Reilly, Robert H MachMolecular Imaging and Biology|September 4, 2015
The PGRMC1 Protein Level Correlates with the Binding Activity of a Sigma-2 Fluorescent Probe (SW120) in Rat Brain CellsChenbo Zeng, Neha Garg, Robert H MachCancers|July 17, 2020
The Biological Function of Sigma-2 Receptor/TMEM97 and Its Utility in PET Imaging Studies in CancerChenbo Zeng, Aladdin Riad, Robert H MachEuropean Journal of Nuclear Medicine and Molecular Imaging|March 24, 2005
Dosimetry of 60/61/62/64Cu-ATSM: a hypoxia imaging agent for PETRichard Laforest, Farrokh Dehdashti, Jason S Lewis, et al.Journal of Chemical Information and Modeling|July 21, 2009
Docking and 3D-QSAR studies on isatin sulfonamide analogues as caspase-3 inhibitorsQi Wang, Robert H Mach, David E ReichertJournal of Medicinal Chemistry|June 6, 2013
The σ2 receptor: a novel protein for the imaging and treatment of cancerRobert H Mach, Chenbo Zeng, William G HawkinsHandbook of Experimental Pharmacology|February 9, 2017
Molecular Probes for Imaging the Sigma-2 Receptor: In Vitro and In Vivo Imaging StudiesChenbo Zeng, Elizabeth S McDonald, Robert H MachDrug Discovery Today. Technologies|December 14, 2017
Inflammation and DNA damage: Probing pathways to cancer and neurodegenerationMehran Makvandi, Mark A Sellmyer, Robert H MachPageof 28